Clostridium Vaccine (Animal Health) Market

Global Clostridium Vaccine (Animal Health) Market Size, Share & Trends Analysis Report, By Animal (Bovine, Ovine, Poultry, Porcine, Equine, and Others), Forecast (2021-2027)

Published: Jan 2022 | Report Code: OMR2025586 | Category : Pharmaceuticals | Delivery Format: /

The global clostridium vaccine (animal health) market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The major factors that are accelerating the growth of the market during the forecast period include the increasing awareness pertaining to zoonotic diseases, the rising incidence rate of clostridium family diseases, and increased awareness regarding animal-derived products. However, side effects associated with vaccines and the high cost of the treatment hamper the market growth during the forecast period. Clostridium bacteria are anaerobic in nature and widely found in the soil and gut of humans and animals. Vaccination plays important role in the protection of animals against clostridial diseases. The vaccines are more commonly used for animals such as bovine, ovine, swine, caprine, poultry, and other animals. A wide variety of vaccines is available in the treatment of clostridial diseases such as single and combination vaccines. The combination vaccines consist of bacterins, toxoids, or mixtures of bacterins and toxoids. 

Moreover, there is a rise in investment in livestock animals, particularly in developing economies. These factors have impacted the clostridium vaccine (animal health) market positively, thus promoting growth. In addition, rising awareness regarding zoonotic diseases and the benefits of clostridium vaccines have led to market growth. Nevertheless, the high dependence on government distribution channels and the high cost of the treatment are some major factors, which can restrain the growth of the market. Geographically, North America is expected to dominate the market owing to the presence of well-established players, increased awareness pertaining to zoonotic diseases, rising incidence rate of clostridium family diseases, increased awareness relating animal-derived products, and increase in disposable income. 

Market Coverage

  • The market number available for – 2020-2027
  • Base year- 2020
  • Forecast period- 2021-2027
  • Segment Covered
  • Regions Covered- Globally

Competitive Landscape: Merck & Co., Inc., Zoetis Inc., and Virbac S.A., among others.  

Key questions addressed by the report

  • What is the market growth rate?
  • Which segment and region dominates the market in base year?
  • Which segment and region will project fastest growth in the market?
  • How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

  • Who is the leader in the market?
  • How players are addressing challenges to sustain growth?
  • Where is the investment opportunity?

Global Clostridium Vaccine (Animal Health) Market Report by Segment

By Animal

Bovine

Ovine

Poultry

Porcine

Equine

Others

Global Clostridium Vaccine (Animal Health) Market by Region

North America

  • United States
  • Canada

Europe

  • UK
  • Germany
  • Italy
  • Spain
  • France
  • Rest of Europe 

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific 

Rest of the World